# LIBERVANT
> **NDA212641** · New Drug Application · Sponsor: AQUESTIVE · Approved 2022-08-30
## Drug
- **FDA Application Number:** NDA212641
- **Application type:** New Drug Application
- **Brand name:** LIBERVANT
- **Generic name:** Diazepam
- **Active ingredients:** DIAZEPAM
- **Dosage form:** FILM
- **Route:** BUCCAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** AQUESTIVE
- **First approval:** 2022-08-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212641)
---
*MORVS · CC0 1.0*